- Report
- January 2024
- 200 Pages
Global
From €4834EUR$5,000USD£4,155GBP
- Report
- June 2020
- 114 Pages
Global
From €4592EUR$4,750USD£3,947GBP
Vibativ (telavancin) is an antibiotic used to treat serious skin and skin structure infections caused by certain bacteria. It is a lipoglycopeptide antibiotic, which works by inhibiting bacterial cell wall synthesis. Vibativ is approved for use in adults and is administered intravenously. It is used to treat infections caused by Gram-positive bacteria, including methicillin-resistant Staphylococcus aureus (MRSA).
The Vibativ market is a niche market within the larger antibiotics market. It is used to treat serious skin and skin structure infections caused by certain bacteria, and is approved for use in adults. Vibativ is a lipoglycopeptide antibiotic, which works by inhibiting bacterial cell wall synthesis.
Some companies in the Vibativ market include Theravance Biopharma, Inc., Merck & Co., Inc., and Pfizer, Inc. Show Less Read more